HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

valyl-valyl-tyrosyl-prolyl-aspartic acid

Also Known As:

MP-5 peptide; Val-Val-Tyr-Pro-Asp; myelopeptide 5

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - valyl-valyl-tyrosyl-prolyl-aspartic acid: 2

Experts

1.	Belyovskaya, R G: 1 article (01/2009)
2.	Kalyuzhnaya, M V: 1 article (01/2009)
3.	Kirilina, E A: 1 article (01/2009)
4.	Shevchenko, V P: 1 article (01/2009)
5.	Ardemasova, Z A: 1 article (07/2008)
6.	Az'muko, A A: 1 article (07/2008)
7.	Belevskaia, R G: 1 article (07/2008)
8.	Efremov, M A: 1 article (07/2008)
9.	Fonina, L A: 1 article (07/2008)
10.	Gur'ianov, S A: 1 article (07/2008)

Related Diseases

1.	Parotitis (Parotiditis) 01/01/2009 - "Myelopeptide-5 (MP-5; synthetic analog of endogenous low-molecular-weight peptide Val-Val-Tyr-Pro-Asp) neutralized the immunosuppressive effects of antiviral vaccines (influenza, measles, and measles/parotitis) and stimulated their immunogenicity by restoring functional activity of T cells, suppressed by the viruses. "
2.	Neoplasms (Cancer) 07/01/2008 - "The MP-5 peptide caused 60-84% inhibition of growth of the following mouse cancers: lymphatic leukemia P-388, melanoma B-16, and cervical carcinoma CUC-5. "
3.	Melanoma (Melanoma, Malignant) 07/01/2008 - "The MP-5 peptide caused 60-84% inhibition of growth of the following mouse cancers: lymphatic leukemia P-388, melanoma B-16, and cervical carcinoma CUC-5. "
4.	Measles 01/01/2009 - "Myelopeptide-5 (MP-5; synthetic analog of endogenous low-molecular-weight peptide Val-Val-Tyr-Pro-Asp) neutralized the immunosuppressive effects of antiviral vaccines (influenza, measles, and measles/parotitis) and stimulated their immunogenicity by restoring functional activity of T cells, suppressed by the viruses. "
5.	Leukemia 07/01/2008 - "The MP-5 peptide caused 60-84% inhibition of growth of the following mouse cancers: lymphatic leukemia P-388, melanoma B-16, and cervical carcinoma CUC-5. "

Related Drugs and Biologics

1.	Vaccines
2.	Peptides (Polypeptides)
3.	Antiviral Agents (Antivirals)